Conarium Bioworks is focused on producing melatonin, “one of the first mainstream consumer products replacing a synthetic compound with a compound that will be fully produced through biomanufacturing”.

This article from UC San Diego Today focuses on bioengineering professor (and Conarium Board member), Bernhard Palsson.